Advancing Treg Therapies in Transplantation Through Clinical Development & Mechanistic Understanding

9:30 am - Wednesday 24th March 2027

  • Reviewing emerging clinical insights from Treg therapies in transplantation to demonstrate progress toward durable graft tolerance
  • Exploring how fundamental Treg biology research is improving understanding of Treg trafficking, persistence, and function in transplant settings
  • Determining how mechanistic and clinical findings can inform the next generation of Treg-based therapies and trial designs in transplantation

Speakers:

Chief Business Officer
Singulera Therapeutics Inc